News

San Antonio biotech acquires U.K. wound-care company

Acelity LP President and CEO Andrew Eckert says the company's acquisition of England's Crawford Healthcare ...

Kiromic founder says Houston biotech’s move to SA nearly a done deal

Houston-based immunotherapy company Kiromic is expected this month to approve moving its headquarters ...

Events

4th Annual SURF 2018

What: San Antonio Military Health System and Universities ResearchForum When: Thursday, June ...

SwRI 2018 International Human Performance Summit

June 30-July 1, 2018 The Summit will be hosted by Southwest Research Institute as part of its ongoing ...
News
Texas Biomedical Research Institute names new CEO
February 4, 2017

Larry Schlesinger was named president and CEO of Texas Biomedical Research Institute. Courtesy Texas Biomed.

By Brittney Martin, San Antonio Express-News

The Texas Biomedical Research Institute in San Antonio chose Dr. Larry Schlesinger, a tuberculosis expert at Ohio State University, as its new president and CEO on Friday.

Schlesinger is currently chair of the Department of Microbial Infection and Immunity and the director of the Center for Microbial Interface Biology at Ohio State University. In addition to leading the institute, Schlesinger will bring with him his ongoing research on immunities to infectious diseases.

"The institute has a reputation for dealing with some of the most difficult medical issues in the world, and I look forward to what we can all accomplish together in the future," Schlesinger said.

Dr. James O. Rubin, chair of the board of trustees, said Schlesinger stood out after an extensive search. He has more than 30 years of experience in the field.

"He is an eminent researcher in his own right and will bring with him a team of experts and funding which will greatly grow our efforts to combat tuberculosis," Rubin said.

Schlesinger will start May 31. Texas Biomedical Research Institute is an independent research institution committed to furthering advancements in global health. Its researchers contribute to the fights against AIDS, malaria, hepatitis and other infectious diseases.

 

Stay informed. Subscribe to BioMed SA news alerts.